Gennex Subsidiary Gets Drug Manufacturing License

Gennex Laboratories Ltd announced that its subsidiary, Deccan Remedies Limited, has received approval from the Drugs Control Administration, Government of Andhra Pradesh. This approval grants a license for the manufacture of several products, including Caffeine, Duloxetine Hydrochloride, Mebeverine Hydrochloride, Phenylephrine Hydrochloride, Trimebutine Maleate, and Oxyclozanide, under Form 25, valid until May 28, 2028. Additionally, Deccan Remedies received a Test License under Form 29 for manufacturing Ranolazine, Cinnarizine, Sacubitril, and Triclabendazole for examination, test, or analysis purposes, valid for three years. These licenses are for both domestic and export markets.